Insulin Management System Market Size (By Product Type - Insulin Pen Injectors, Needle And Syringe, Insulin Jet Injectors, Implantable Pumps, External Insulin Pumps, Insulin Patches; By Mode Of Action - Short Acting Insulin, Intermediate Acting Insulin, Rapid Acting Insulin, Pre-Mixed Insulin; By Diabetes Type - Diabetes I, Diabetes II; By End User - Hospital & Clinics, Ambulatory Centers) - Global Industry Size, Share, Trends, And Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 180

Introduction

Diabetes is a metabolic disease in which consist of elevated blood glucose levels over a prolonged period. It is caused due to either pancreas not able to produce enough insulin or cells of the body not responding to the insulin produced. Insulin management system helps to deliver the insulin to the body of the patient. A number of different types of insulin delivery products are available in the market which includes insulin pen injectors, needle and syringe, insulin jet injectors, implantable pumps, external insulin pumps, insulin patches, and others.

 Market Dynamics

The major driving factor for the market is increasing prevalence of the diabetes. According to the report published by the WHO, in 2014, approximately 422 million people across the globe were suffering from diabetes. Additionally, obesity and smoking are the major factors for the increasing the diabetic population. Increasing number of people suffering from obesity and adoption of smoking by people have fueled the growth of the market. Moreover, increased the demand for the better treatment option, increasing healthcare expenditure, increasing government support and advancement in the technology have boosted the growth of the market during the forecast period 2018—2026.However, high costs of syringes, lack of awareness among the people is the major factors hindering the growth of the market.

In near future the market is expecting a healthy opportunity owing to the continuous increasing demand for the better and better products.

Market Classification and Overview

The global insulin management system market is majorly segmented into product type, mode of action, diabetes type, and end users.

On the basis of product type, the market is segmented into Insulin pen injectors, needle and syringe, insulin jet injectors, implantable pumps, external insulin pumps, insulin patches, and others

On the basis of mode of action, the market is segmented into short acting insulin, intermediate acting insulin, rapid acting insulin, pre-mixed insulin.

On the basis of diabetes type, the market is segmented into type-I diabetes, type-IIdiabetes.

On the basis of end users, the market is segmented into hospital & clinics, ambulatory centre, and other.

Regional Overview

Globally, the insulin management system market is segmented into North America, Europe, Asia Pacific and Latin America, Middle East & Africa.

North America is expected to dominate the insulin management system market owing to their advancement in technology, huge diabetic population and high healthcare spending. Additionally, increasing government support and presence of a huge number of players will support the growth of the market.

Europe accounts for the second leading market in the forecast period followed by the Asia Pacific. Well developed economies and huge government support in this region have driven the growth of the market.Asia Pacific region is expected to have the fastest growth during the forecast period owing to huge number of diabetic and obese population of the region. According to the International Diabetes Federation (IDF), over 60% of total global diabetic population is in Asia Pacific of which over 114 million are present in China. Additionally, increasing per capita income and increasing government support have fueled the growth of the market. LAMEA region is expected to show healthy growth during the forecast period 2018—2026. Increasing per capita income and presence of huge untapped opportunities is driving the growth of the market. Additionally, lack of medical facilities Africa region creates an opportunity for key players to expand the market in this region.

Report Coverage

Market

Insulin Management System  Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

 Product Type, Mode of Action, Diabetes Type, End Users, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

 

Market Participants

Some of the major key players in the market are Abbott, Accu-Chek, Eli Lilly, Bayer, Animas, DexCom, Medtronic, Roche, LifeScan, Novo Nordisk, Merck, Novartis, Sanofi-aventis, Takeda Pharmaceuticals, and Bristol-Myers Squibb.

Market Segmentation

Market By Product Type

  • Insulin Pen Injectors
  • Needle and syringe
  • Insulin jet injectors
  • Implantable pumps
  • External Insulin pumps
  • Insulin patches

Market By Mode of Action

  • Short acting insulin
  • Intermediate acting insulin
  • Rapid acting insulin
  • Pre-mixed insulin

Market By Diabetes Type

  • Diabetes I
  • Diabetes II

Market By End User

  • Hospital & Clinics
  • Ambulatory canters
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA


Related Reports

Hemophilia Market (By Type: Hemophilia A, Hemophilia B, Hemophilia C; By Treatment: On-demand, Prophylaxis; By Therapy: Replacement Therapy, Gene Therapy) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global Hemophilia market is estimated to hit nearly USD 17 billion by 2026. The hemophilia market islikely to grow with 5.3% CAGR during the forecast years. Market Dynamics The increasing initiatives at the global level to create awareness about hemophilia dr

Angiography Devices Market (By Product: Catheters, Contrast Media, Angiography Systems, Balloons, Vascular Closure Devices, Angiography Accessories; By Technology: MRA, CT, X-Ray; By Procedure: Endovascular, Coronary, Neurovascular; By Application: Therapeutic, Diagnostic) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global angiography devices Market is projected to worth $16.1 Billion by 2026 and the market is projected to showcase 6.3% CAGR during the forecast period. The angiography devices market is driven by the continuous development in imaging technology for various applications in the healthcare industry. Mar

Diagnostic Ultrasound Market (By Technology: 2D, 3D and 4D, Doppler; By Portability: Trolley, Compact/Handheld; By Application: General Imaging, Cardiology, OB/GYN, Others; By End-user: Hospitals, Maternity Centres, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Diagnostic ultrasound is an ultrasound application based method. Diagnostic ultrasound technique is used to create an image of structures of internal body such as muscles, blood vessels, tendons, joints and other internal organs. Its aim is to exclude pathology or find a source of a disease. Diagnostic ultrasound is also used for examining pregnant women. The report provides analysis of global

Breast Implants Market (By Product: Silicone Implant, Saline Implant; By Shape: Round, Anatomical; By Application: Breast Augmentation, Breast Reconstruction; By Texture: Smooth, Textured; By End Use: Hospitals, Clinics, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction Breast implants are medical devices that are used to enlarge the size of breasts either for cosmetic applications or rebuilding purpose. Breast expansion, generally called as breast enlargement, is a popular surgical method that enhances the shape and size of the breast. This method includes the use of breast implants in order to improve the size of the breasts. In clinical terms, breast expan

Urology Devices Market (By Product: Dialysis, Laser & Lithotripsy, Robotic Systems, Endoscopes, Endovision System & Peripheral Instruments, Urodynamic Systems, Stents, Urology Catheters, Urology Guidewires, Urodynamic Systems, Drainage Bags, Others; By End-user: Dialysis Centers, Hospitals, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global urology devices Market is projected worth US$57.4 billion by 2026 and the market is projected to showcase 6.9% CAGR during the forecast period. The urology devices market is driven by the easy availability of urology devices and high occurrence of urology disorder associated with the urinary tract system (UTS) across the globe.

Pet Cancer Therapeutics Market (By Medicine Type: Vaccines, Chemotherapy Drugs; By Species: Dogs, Cats; By Cancer Type: Melanoma, Squamous Cell Cancer, Mast Cell Cancer, Mammary, Lymphoma) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Introduction The global pet cancer therapeutics Market is projected worth US$345.2 million by 2026 and the market is projected to showcase 10.6% CAGR during the forecast period. The pet cancer therapeutics market is driven by the rapid adoption of innovative pet care medicines. Market Dynamics

Cart Summary